Market Tracker

09/01 6:05pm ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

14.85
Data as of Aug 29
 +0.40 / +2.77%
Today’s Change
9.01
Today|||52-Week Range
21.00
+25.85%
Year-to-Date

Today’s Trading

Previous close14.45
Today’s open14.35
Day’s range14.35 - 14.94
Volume2,180
Average volume (3 months)10,385
Market cap$130.4M
Dividend yield--
Data as of 3:21pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+14.73%
Earnings growth (this year)+20.59%
Earnings growth (next 5 years)--
Revenue growth (last year)-24.76%
P/E ratio--
Price/Sales6,117.05
Price/Book10.88

Competitors

 Today’s
change
Today’s
% change
NERVMinerva Neuroscience...+0.14+2.02%
RNNRexahn Pharmaceutica...0.000.00%
EVARLombard Medical Inc+1.18+18.15%
AMBIAmbit Biosciences Co...+0.47+6.62%
Data as of 4:00pm ET, 08/29/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$12.0K
Annual profit (last year)-$10.7M
Net profit margin-88,566.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Director, Deputy CEO-Finance &
Operations
Ori Shilo
Corporate headquarters
Tel Aviv, --

Forecasts